about
Efficient tumour formation by single human melanoma cellsStem cells: potency, plasticity and public perceptionA New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem CellsIn vivo molecular imaging of cancer stem cellsInduction of pluripotency by defined factorsPluripotent stem cell-derived neural stem cells: From basic research to applicationsDefining synthetic surfaces for human pluripotent stem cell cultureThe "virgin birth", polyploidy, and the origin of cancerDisease modeling using human induced pluripotent stem cells: lessons from the liverProgress and bottleneck in induced pluripotencyTumour heterogeneity and cancer cell plasticitySimultaneous detection of mRNA and protein stem cell markers in live cellsLinking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cellsRegulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.Differentiating embryonic stem cells pass through 'temporal windows' that mark responsiveness to exogenous and paracrine mesendoderm inducing signals.Hypoxic tumor microenvironment and cancer cell differentiation.Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitroNormal genetically mosaic mice produced from malignant teratocarcinoma cellsTotipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocystsDifferentiation as a requirement for simian virus 40 gene expression in F-9 embryonal carcinoma cellsTumorigenicity of embryonal carcinoma as an assay to study control of malignancy by the murine blastocyst.Whole-body protochordate regeneration from totipotent blood cellsTumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic miceSomatic cell origin of teratocarcinomasTumor reversion: correction of malignant behavior by microenvironmental cuesEmbryonic stem cell-derived factors inhibit T effector activation and induce T regulatory cells by suppressing PKC-θ activation.Induced pluripotency: history, mechanisms, and applications.The ter mutation in the rat Dnd1 gene initiates gonadal teratomas and infertility in both gendersFrom stealing fire to cellular reprogramming: a scientific history leading to the 2012 Nobel Prize.Pluripotency and its layers of complexity.Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell lineFrom teratocarcinomas to embryonic stem cellsAssociation between tumorigenic potential and the fate of cancer cells in a syngeneic melanoma model.Alkaline phosphatase activity in mouse teratoma.Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells.Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention.Expression of the intracisternal A-particle is elevated during differentiation of embryonal carcinoma cells.p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome.In vitro generation of human cells with cancer stem cell properties.
P2860
Q24648938-DBB38A3F-5827-43C2-8668-9DA570E1D8EEQ24676055-EAE983CB-5758-4802-8FC9-A5FFB772B539Q26744651-4AC177D0-68BE-40A9-86CB-AD04356273DBQ26828630-769955BB-844E-4339-A417-B17155579FBFQ26830425-2CB34CBC-76BD-4DBE-B2E0-1C70FE531855Q27009132-944D79C7-35E3-4092-A0B9-0C030625C132Q27014667-ADDC5CB4-FD44-434B-9CCB-A33149BE2CE5Q27024916-8CC6B36F-FA24-4EEE-932D-979E94F2068AQ28650516-01BE94A6-4411-40B5-B5F4-3E001A05C223Q28652287-215026ED-1FCF-40D9-8472-AF8C987D762FQ29617990-B6284DEA-8729-433F-91D4-223EC349545BQ33426068-79395C7E-1734-488F-A3EF-C2B33D48A007Q33570419-61F231C2-16EF-4DBB-B90B-9B453729C384Q33587316-53A92B97-F1BC-4CEB-87C5-66016048021AQ33587418-FA2C6307-A4CB-4758-8600-97DD10B4C0F0Q33670820-3D5B95F4-7789-4455-A0FA-87A38BC34EB4Q33879584-23B3E1A9-E8F8-4FCA-9299-77178946B88BQ33883130-A660BFFB-CE3D-4224-8B49-191E7780EC4EQ33884846-B5CF106A-C7D1-4B12-BAD6-2E1C555B5B41Q33979330-63374737-E69D-4D90-9D85-69EF2FDDFE50Q33990816-BA56CC91-2D23-4488-97A9-CB6209CFE594Q33999729-1535ADB5-C3FC-441F-AC84-C434E4AC50CDQ34038759-E6A5714D-B6BD-46A7-9396-027DC29334E3Q34047350-EFC61D50-5EA5-436F-B571-C74C6DFB38C4Q34103266-F865997D-BC4E-447D-BBCF-10B546152927Q34193128-D4C70394-B3DF-49B9-B770-5296ED32B89AQ34206028-E1477BEB-257A-4B70-AFD4-51E824AA496BQ34289178-6444651D-D81D-4056-A6E0-BD3BBB4C12D8Q34372447-2F83CB01-7E58-450D-8E78-070B145489ACQ34503625-D2E91728-CAE9-46CF-9450-A68250C3831DQ34540318-6407087E-8B72-4363-8A59-FCF758E9E1ECQ34544440-7E602604-9E9B-4800-9ECD-FF94E6CCBF4EQ34655798-DFF10D93-586F-4712-BD71-F2BB52CFC8AEQ34692759-2D8F0D80-9795-4017-8D1B-00076EE28419Q34754622-FE58CCBA-6716-415A-9FE9-E07B0B9A28D8Q34938156-07DA2A30-EB99-46DF-8F2B-EECB37BBBF6BQ34968735-C5B51D46-C14F-4A1F-A5B3-DE260F9C4D38Q35061537-C0D667A0-382E-4432-ACC2-EE0207085F29Q35103179-40C60BDA-001C-4355-91FF-B78A1F97B18DQ35196349-ABB1570A-CBEB-4E91-8CFE-7D6C5138B47E
P2860
description
1964 nî lūn-bûn
@nan
1964 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1964 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1964年の論文
@ja
1964年論文
@yue
1964年論文
@zh-hant
1964年論文
@zh-hk
1964年論文
@zh-mo
1964年論文
@zh-tw
1964年论文
@wuu
name
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.
@ast
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.
@en
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.
@nl
type
label
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.
@ast
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.
@en
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.
@nl
prefLabel
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.
@ast
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.
@en
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.
@nl
P1433
P1476
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS
@en
P2093
KLEINSMITH LJ
PIERCE GB Jr
P304
P407
P577
1964-10-01T00:00:00Z